首页> 美国政府科技报告 >Glycophorin A (GPA) Biodosimetry in I-131 Treated Patients
【24h】

Glycophorin A (GPA) Biodosimetry in I-131 Treated Patients

机译:I-131治疗患者的血型糖蛋白a(Gpa)生物剂量学

获取原文

摘要

This research evaluated the in vivo glycophorin A-based somatic cell mutation assay as a retrospective biodosimeter for use in epidemiologic studies. The response of the assay as a biodosimeter of radiation exposure was validated in a longitudinal study of patients receiving I-131 therapy for thyroid disease. Assessment of the glycophorin A assay in this project demonstrated that assay results are substantially reduced for low dose/low dose rate radiation exposures.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号